These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35658899)

  • 1. Immunological characteristics of MAV/06 strain of varicella-zoster virus vaccine in an animal model.
    Shin D; Shin Y; Kim E; Nam H; Nan H; Lee J
    BMC Immunol; 2022 Jun; 23(1):27. PubMed ID: 35658899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.
    Choi UY; Huh DH; Kim JH; Kang JH
    Hum Vaccin Immunother; 2016 Oct; 12(10):2560-2564. PubMed ID: 27484734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella-zoster virus.
    Hwang JY; Kim Y; Lee KM; Shin OS; Gim JA; Shin Y; Park H
    Hum Vaccin Immunother; 2023 Dec; 19(1):2210961. PubMed ID: 37218543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
    Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH
    Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
    Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of children with malignant disease against varicella.
    Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
    Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
    Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
    J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Constitutive Interleukin 10 Level Interferes With the Immune Response to Varicella-Zoster Virus in Elderly Recipients of Live Attenuated Zoster Vaccine.
    Gershon AA; Brooks D; Stevenson DD; Chin WK; Oldstone MBA; Gershon MD
    J Infect Dis; 2019 Apr; 219(8):1338-1346. PubMed ID: 30445431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
    Bakker KM; Eisenberg MC; Woods RJ; Martinez ME
    BMC Med; 2022 Oct; 20(1):387. PubMed ID: 36209074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
    Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Responses to Varicella-Zoster Virus Vaccines.
    Levin MJ; Weinberg A
    Curr Top Microbiol Immunol; 2023; 438():223-246. PubMed ID: 35102438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A booster administration of the OKA/SK strain causes fatal disseminated varicella in an immunocompetent child.
    Kang HM; Kang KR; Kim YJ; Kang JH; Lee SY
    J Med Virol; 2023 Sep; 95(9):e29108. PubMed ID: 37715715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine.
    Perciani CT; Jaoko W; Walmsley S; Farah B; Mahmud SM; Ostrowski M; Anzala O; Team KI; MacDonald KS
    BMJ Open; 2017 Sep; 7(9):e017391. PubMed ID: 28939581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka.
    Umit Z; Sahbudak Bal Z; Zeytinoglu A; Gulbahar Aydogan T; Bag O; Guner Ozenen G; Ozkinay F; Kurugol Z
    Hum Vaccin Immunother; 2021 Nov; 17(11):4190-4193. PubMed ID: 34643479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines.
    Schmid DS; Miao C; Leung J; Johnson M; Weinberg A; Levin MJ
    J Virol; 2021 May; 95(12):. PubMed ID: 33762414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of varicella-zoster virus vaccine by different routes of administration: Comparable vaccination efficacy of one-fifth dose intradermal vaccination to conventional subcutaneous vaccination.
    Nakamura-Nishimura Y; Shinkuma S; Miyagawa F; Haredy A; Gomi Y; Yamanishi K; Asada H
    J Dermatol Sci; 2022 May; 106(2):86-92. PubMed ID: 35437206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents.
    Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Wittke F; Jotterand V
    Hum Vaccin Immunother; 2021 Nov; 17(11):4183-4189. PubMed ID: 34702124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
    Berger R; Luescher D; Just M
    Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.